Idiopathic Intracranial Hypertension.

Autor: Anderson M; Department of Neurological Surgery, University of Washington, Seattle, WA, USA., Baird-Daniel E; Department of Neurological Surgery, University of Washington, Seattle, WA, USA., Meyer RM; Department of Neurological Surgery, University of Washington, Seattle, WA, USA., Levitt MR; Department of Neurological Surgery, University of Washington, Seattle, WA, USA; Stroke & Applied Neuroscience Center, University of Washington, Seattle, WA, USA; Department of Radiology, University of Washington, Seattle, WA, USA; Department of Mechanical Engineering, University of Washington, Seattle, WA, USA; Department of Neurology, University of Washington, Seattle, WA, USA. Electronic address: mlevitt@uw.edu.
Jazyk: angličtina
Zdroj: Neurosurgery clinics of North America [Neurosurg Clin N Am] 2024 Jul; Vol. 35 (3), pp. 287-291. Date of Electronic Publication: 2024 Mar 19.
DOI: 10.1016/j.nec.2024.02.001
Abstrakt: Idiopathic intracranial hypertension is defined by headaches and a decline in visual acuity due to increased intracranial pressure. Treatment options historically included weight loss, acetazolamide, and/or cerebrospinal fluid diversion surgery. Recent understanding of the contributions of dural venous sinus hypertension and stenosis has led to venous sinus stenting as a treatment option.
Competing Interests: Disclosure M.R. Levitt received unrestricted educational grants from Stryker, United States and Medtronic, has equity interest in Synchron, Proprio, Apertur, Stroke Diagnostics, Hyperion Surgical, Stereotaxis, and Fluid Biomed, serves on the editorial board of Journal of NeuroInterventional Surgery and Frontiers in Surgery, serves on the data safety monitoring board for Arsenal Medical, and is a consultant for Aeaean Advisers and Metis Innovative. M. Anderson received unrestricted educational grants from Cerenovus and Microvention. E. Baird-Daniel and R.M. Meyer have no disclosures.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE